The effectiveness of using Prolia drug on bone density
Phase 3
Recruiting
- Conditions
- Bone density.
- Registration Number
- IRCT20191030045282N1
- Lead Sponsor
- Deputy of research and technology of Alborz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
The patient should have informed consent to participate in the intervention
The patient should be undergone hemodialysis courses
The patient has a medical diagnosis of osteoporosis
Exclusion Criteria
The patient does not have conscious consent to participate in the intervention
The patient does not have a medical diagnosis of osteoporosis
The patient has a history of previous fractures
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone density. Timepoint: The amount of bone density will be measured before the intervention and one month after the subcutaneous injection of the prolia drug. Method of measurement: Bone density measurement test.
- Secondary Outcome Measures
Name Time Method